Expanding Eosinophilic Esophagitis Research: An Interview with Dr. Evan Dellon (Pt. 1)
Dr. Evan Dellon

Expanding Eosinophilic Esophagitis Research: An Interview with Dr. Evan Dellon (Pt. 1)

The U.S. Food and Drug Administration (FDA) approved Dupixent for the treatment of moderate-to-severe atopic dermatitis in patients aged 6 months+; the drug is also approved as add-on maintenance therapy…

Continue Reading Expanding Eosinophilic Esophagitis Research: An Interview with Dr. Evan Dellon (Pt. 1)
Webinar: Improving Classical Homocystinuria Outcomes Through Newborn Screening
source: shutterstock.com

Webinar: Improving Classical Homocystinuria Outcomes Through Newborn Screening

On September 8, 2022, HCU Network America, a Patient Worthy partner organization, hosted a webinar program titled "Classical Homocystinuria: A Journey to Improve Outcomes Through Newborn Screening Methodology." The webinar…

Continue Reading Webinar: Improving Classical Homocystinuria Outcomes Through Newborn Screening
September 24 is Familial Hypercholesterolemia Awareness Day
source: pixabay.com

September 24 is Familial Hypercholesterolemia Awareness Day

September 24, 2022 will be recognized as Familial Hypercholesterolemia (FH) Awareness Day, a time to spread awareness about this under-recognized condition among the general public and in the medical field.…

Continue Reading September 24 is Familial Hypercholesterolemia Awareness Day
Lupus Nephritis: Belimumab Alongside Standard Treatment Improves Outcomes in East Asians
source: shutterstock.com

Lupus Nephritis: Belimumab Alongside Standard Treatment Improves Outcomes in East Asians

According to a story published in Healio, a recent study has concluded that a combination of standard treatment and belimumab produces better outcomes for patients of East Asian descent living with…

Continue Reading Lupus Nephritis: Belimumab Alongside Standard Treatment Improves Outcomes in East Asians
Study of the Week: A Device That Can Detect Alzheimer’s 17 Years Before Symptoms Start
source: pixabay.com

Study of the Week: A Device That Can Detect Alzheimer’s 17 Years Before Symptoms Start

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: A Device That Can Detect Alzheimer’s 17 Years Before Symptoms Start

Editor’s Choice: A Biomarker for Early Alzheimer’s Detection, A Teen Living with Usher Syndrome, and A Possible Chagas Disease Treatment

Happy Monday! This week, we have details on a method for detecting Alzheimer's 17 years in advance, the story of a teen living with Usher syndrome, and a possible breakthrough…

Continue Reading Editor’s Choice: A Biomarker for Early Alzheimer’s Detection, A Teen Living with Usher Syndrome, and A Possible Chagas Disease Treatment

Immunotherapy Before Surgery Increases Survival in Cutaneous Squamous Cell Carcinoma

Medical science takes a giant leap with a process that sees tumors disappearing or significantly shrinking in 63.3 percent of cutaneous squamous cell carcinoma (CSCC) patients. According to a recent…

Continue Reading Immunotherapy Before Surgery Increases Survival in Cutaneous Squamous Cell Carcinoma